Income Statement GuiZhou SanLi Pharmaceutical Co.,Ltd

Stocks

603439

CNE1000040B4

Pharmaceuticals

End-of-day quote Shanghai S.E. 2026-09-11			5-day change	1st Jan Change
12.54 ^CNY	+10.00%		+2.53%	+7.18%

08-27	Guizhou Sanli Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2026	CI
05-26	Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement	MT

eba6b57cad09990d41.8ZOsC-jfDPHTo9OoJUyys-Yq6ZYVyRlUrdWHb6daFl8.qOvbe97qb5WBlIDsVTjd67EZh9REviAf4ofOOOI5JDm0_u1ngLRpmoLN5w

Published financial data: GUIZHOU SANLI PHARMACEUTICAL CO.,LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Revenues	939M	1.2B	1.63B	2.14B	1.7B
Other Revenues, Total	131K	334K	512K	548K	859K
Total Revenues	939M	1.2B	1.63B	2.14B	1.7B
Cost of Goods Sold, Total	277M	340M	438M	653M	519M
Gross Profit	662M	862M	1.2B	1.49B	1.18B
Selling General & Admin Expenses, Total	493M	618M	879M	1.09B	948M
Provision for Bad Debts	987K	10.3M	3.35M	9.9M	-5.58M
R&D Expenses	7.68M	17.86M	30.61M	46.5M	27.91M
Other Operating Expenses	8.56M	11.01M	16.6M	17.31M	26.81M
Other Operating Expenses, Total	510M	657M	930M	1.16B	997M
Operating Income	152M	205M	267M	328M	186M
Interest Expense, Total	-8.34M	-5.24M	-4.13M	-14.61M	-11.07M
Interest And Investment Income	25.81M	17.56M	60.13M	5.8M	3.96M
Net Interest Expenses	17.47M	12.32M	56M	-8.81M	-7.12M
Other Non Operating Income (Expenses)	-92.82K	-206K	1.89M	-368K	-54.76K
EBT, Excl. Unusual Items	169M	217M	325M	319M	179M
Impairment of Goodwill	-	-80K	-	-	-122M
Gain (Loss) On Sale Of Investments	-	-88.91K	-	145K	-2.62M
Gain (Loss) On Sale Of Assets	-149K	-88.86K	589K	-172K	-116K
Asset Writedown	-6.58K	-104K	-48.98K	-573K	-31.97K
Other Unusual Items	7.51M	6.18M	8.38M	6.47M	13.62M
EBT, Incl. Unusual Items	177M	223M	334M	325M	67.77M
Income Tax Expense	28.05M	30.62M	39.15M	45.19M	19.61M
Earnings From Continuing Operations	149M	192M	295M	280M	48.15M
Net Income to Company	149M	192M	295M	280M	48.15M
Minority Interest	3.68M	9.35M	-2.17M	-5.81M	-1.9M
Net Income - (IS)	152M	201M	293M	274M	46.25M
Net Income to Common Incl Extra Items	152M	201M	293M	274M	46.25M
Net Income to Common Excl. Extra Items	152M	201M	293M	274M	46.25M
Per Share Items
Net EPS - Basic	0.37	0.49	0.71	0.67	0.11
Basic EPS - Continuing Operations	0.37	0.49	0.71	0.67	0.11
Basic Weighted Average Shares Outstanding	412M	411M	412M	409M	420M
Net EPS - Diluted	0.37	0.49	0.71	0.67	0.11
Diluted EPS - Continuing Operations	0.37	0.49	0.71	0.67	0.11
Diluted Weighted Average Shares Outstanding	412M	411M	412M	409M	420M
Normalized Basic EPS	0.27	0.35	0.49	0.47	0.26
Normalized Diluted EPS	0.27	0.35	0.49	0.47	0.26
Dividend Per Share	-	0.1	0.2	0.34	0.06
Payout Ratio	72.37	4.43	17.4	37.97	349.04
Supplemental Items
EBITDA	163M	220M	303M	402M	259M
EBITA	153M	207M	281M	347M	204M
EBIT	152M	205M	267M	328M	186M
EBITDAR	163M	221M	306M	405M	261M
Total Revenues (As Reported)	939M	1.2B	1.63B	2.14B	1.7B
Effective Tax Rate - (Ratio)	15.88	13.76	11.72	13.9	28.94
Current Domestic Taxes	-	30.66M	-	-	-
Total Current Taxes	28.41M	30.66M	43.31M	52.65M	23.95M
Deferred Domestic Taxes	-	-40.6K	-	-	-
Total Deferred Taxes	-364K	-40.6K	-4.16M	-7.46M	-4.34M
Normalized Net Income	109M	145M	201M	194M	110M
Interest on Long-Term Debt	-	-	26.59K	29.28K	29.28K
Non-Cash Pension Expense	-	-	-	-	4.06M
Supplemental Operating Expense Items
Advertising Expense	7.37K	2.29M	1.78M	1.47M	212K
Marketing Expenses	339M	371M	573M	713M	573M
Selling and Marketing Expenses	451M	565M	794M	943M	801M
General and Administrative Expenses	41.9M	53.09M	84.75M	146M	147M
Research And Development Expense From Footnotes	7.68M	17.86M	30.61M	46.5M	27.91M
Net Rental Expense, Total	384K	929K	2.77M	2.28M	2.32M
Imputed Operating Lease Interest Expense	128K	192K	241K	459K	301K
Imputed Operating Lease Depreciation	256K	737K	2.53M	1.82M	2.02M
Stock-Based Comp., S&M Exp. (Total)	214K	-214K	-	120K	772K
Stock-Based Comp., G&A Exp. (Total)	543K	6.52M	4.14M	-15.16K	12.95M
Stock-Based Comp., Other (Total)	-	-	-	42.47K	-
Total Stock-Based Compensation	757K	6.3M	4.14M	148K	13.73M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Assets
Cash And Equivalents	544M	571M	571M	476M	390M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	98M	59.91M	51.5M	22.95M	19.93M
Total Cash And Short Term Investments	642M	631M	623M	499M	410M
Accounts Receivable, Total	313M	433M	683M	932M	858M
Other Receivables	51.41M	2.18M	3.32M	2.53M	-383K
Total Receivables	364M	435M	686M	935M	858M
Inventory	88.57M	98.08M	176M	321M	222M
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	4.55M	8.18M	8.69M	43.59M	39.6M
Total Current Assets	1.1B	1.17B	1.49B	1.8B	1.53B
Gross Property Plant And Equipment	215M	334M	895M	917M	919M
Accumulated Depreciation	-57.56M	-96.64M	-280M	-332M	-373M
Net Property Plant And Equipment	158M	237M	615M	585M	546M
Long-term Investments	119M	130M	10.08M	22.55M	89.6M
Goodwill	-	162M	555M	555M	433M
Other Intangibles, Total	20.38M	107M	235M	216M	194M
Deferred Tax Assets Long-Term	5.12M	6.89M	11.08M	15.13M	15.79M
Deferred Charges Long-Term	2.9M	1.54M	856K	563K	659K
Other Long-Term Assets, Total	-	-	-	-	39.81M
Total Assets	1.4B	1.82B	2.92B	3.19B	2.85B
Liabilities
Accounts Payable, Total	98.84M	165M	248M	343M	101M
Accrued Expenses, Total	16.59M	31.33M	39.48M	67.33M	78.68M
Short-term Borrowings	200M	205M	255M	352M	549M
Current Portion of Long-Term Debt	-	-	45.22M	45.15M	59.8M
Current Portion of Leases	-	499K	151K	503K	106K
Current Income Taxes Payable	9.4M	10.91M	12.77M	13.84M	10.51M
Unearned Revenue Current, Total	5.83M	78.96M	8.17M	7.79M	5.47M
Other Current Liabilities	29.76M	56.72M	230M	406M	233M
Total Current Liabilities	360M	549M	839M	1.23B	1.04B
Long-Term Debt	-	-	254M	209M	150M
Long-Term Leases	-	170K	168K	212K	26.46K
Unearned Revenue Non Current	12.5M	12.5M	35.97M	42.97M	39.19M
Deferred Tax Liability Non Current	-	6.94M	28.88M	25.5M	21.99M
Other Non Current Liabilities	-	10.1M	52.92M	85.04M	87.59M
Total Liabilities	373M	578M	1.21B	1.6B	1.34B
Common Stock, Total	411M	411M	410M	410M	409M
Additional Paid In Capital	223M	230M	225M	149M	153M
Retained Earnings	424M	625M	877M	1.07B	978M
Treasury Stock	-26.55M	-26.55M	-41.43M	-101M	-94.35M
Total Common Equity	1.03B	1.24B	1.47B	1.53B	1.45B
Minority Interest	607K	-823K	239M	67.29M	66.63M
Total Equity	1.03B	1.24B	1.71B	1.59B	1.51B
Total Liabilities And Equity	1.4B	1.82B	2.92B	3.19B	2.85B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	411M	411M	408M	406M	405M
ECS Total Common Shares Outstanding	411M	411M	408M	406M	405M
Book Value / Share	2.51	3.02	3.6	3.77	3.57
Tangible Book Value	1.01B	970M	680M	757M	819M
Tangible Book Value Per Share	2.46	2.36	1.67	1.87	2.02
Total Debt	200M	206M	555M	607M	758M
Net Debt	-442M	-425M	-67.86M	108M	349M
Debt Equivalent Oper. Leases	3.07M	7.44M	22.18M	18.24M	18.53M
Minority Interest, Total (Incl. Fin. Div)	607K	-823K	239M	67.29M	66.63M
Equity Method Investments, Total	119M	130M	79.55K	12.55M	79.6M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	10.26M	14.18M	84.58M	61.26M	51.91M
Inventories - Work In Process, Total	37.01M	57.45M	31.68M	78.8M	47.95M
Inventories - Finished Goods, Total	38.89M	22.53M	6.06M	171M	116M
Inventories - Others	2.47M	3.93M	55.87M	12.94M	15.63M
Buildings, Total	153M	181M	549M	543M	503M
Machinery, Total	58.44M	103M	345M	351M	353M
Full Time Employees	1.01K	1.56K	2.28K	2.85K	1.89K
Accumulated Allowance for Doubtful Accounts (Supple)	13.96M	19.99M	29.77M	39.66M	34.05M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Net Income	152M	201M	293M	274M	46.25M
Depreciation & Amortization - CF	10.35M	13.49M	23.08M	56.62M	55.74M
Amortization of Goodwill and Intangible Assets - (CF)	799K	2.47M	13.38M	18.24M	18.29M
Depreciation & Amortization, Total	11.14M	15.96M	36.46M	74.86M	74.02M
Amortization of Deferred Charges, Total - (CF)	71.76K	1.89M	1.13M	1.15M	899K
(Gain) Loss From Sale Of Asset	149K	88.86K	-589K	172K	116K
(Gain) Loss on Sale of Investments - (CF)	-17.87M	-10.96M	-55.16M	-1.96M	2.62M
Asset Writedown & Restructuring Costs	72.88K	184K	48.98K	573K	122M
Provision and Write-off of Bad Debts	987K	10.3M	3.35M	9.9M	-5.58M
Other Operating Activities, Total	4.73M	-3.95M	10.89M	31.51M	34.46M
Change In Accounts Receivable	-83.04M	-79.55M	-124M	-296M	196M
Change In Inventories	-41.13M	-9.45M	-7.06M	-148M	92.68M
Change In Accounts Payable	127M	161M	119M	168M	-409M
Change In Deferred Taxes	-364K	-40.6K	-4.16M	-7.46M	-4.17M
Change in Other Net Operating Assets	757K	6.3M	4.14M	148K	13.73M
Cash from Operations	155M	293M	277M	107M	165M
Capital Expenditure	-26.08M	-120M	-109M	-45.2M	-25.84M
Sale of Property, Plant, and Equipment	50K	177K	2.05M	549K	640K
Cash Acquisitions	-	-160M	-543M	-	-
Divestitures	-	649K	-6.94K	-	-94.65K
Investment in Marketable and Equity Securities, Total	80.7M	38M	34.5M	-59.96M	-204M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-27.36M	-	-	-
Other Investing Activities, Total	-34.08M	1.92M	1.45M	1.61M	658K
Cash from Investing	20.59M	-267M	-614M	-103M	-228M
Short Term Debt Issued, Total	200M	205M	-	-	-
Long-Term Debt Issued, Total	-	-	504M	351M	571M
Total Debt Issued	200M	205M	504M	351M	571M
Short Term Debt Repaid, Total	-200M	-200M	-	-	-
Long-Term Debt Repaid, Total	-	-	-205M	-310M	-423M
Total Debt Repaid	-200M	-200M	-205M	-310M	-423M
Issuance of Common Stock	26.55M	-	-	39.22M	-
Repurchase of Common Stock	-	-	-30M	-100M	-7.73M
Common Dividends Paid	-110M	-8.92M	-50.92M	-104M	-161M
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-110M	-8.92M	-50.92M	-104M	-161M
Other Financing Activities, Total	2.2M	3.8M	120M	23.12M	-
Cash from Financing	-81.46M	-125K	338M	-101M	-21.57M
Net Change in Cash	94.17M	26.6M	551K	-96.53M	-85.43M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	100M	116M	175M	211M	191M
Levered Free Cash Flow	54.78M	128M	-36.78M	97.65M	-57.52M
Unlevered Free Cash Flow	59.99M	131M	-34.2M	107M	-50.6M
Change In Net Working Capital	20.85M	-98.82M	134M	129M	230M
Net Debt Issued / Repaid	0	5M	299M	41.52M	148M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Profitability
Return on Assets	7.13	7.94	7.05	6.71	3.85
Return on Total Capital	7.87	9.56	9.01	9.19	5.2
Return On Equity %	14.76	16.91	20.01	16.94	3.1
Return on Common Equity	15.13	17.73	21.61	18.28	3.11
Margin Analysis
Gross Profit Margin %	70.49	71.74	73.21	69.55	69.5
SG&A Margin	52.48	51.44	53.78	50.8	55.69
EBITDA Margin %	17.37	18.33	18.54	18.76	15.2
EBITA Margin %	16.26	17.24	17.16	16.16	12
EBIT Margin %	16.18	17.03	16.34	15.31	10.93
Income From Continuing Operations Margin %	15.83	15.98	18.04	13.05	2.83
Net Income Margin %	16.22	16.76	17.9	12.78	2.72
Net Avail. For Common Margin %	16.22	16.76	17.9	12.78	2.72
Normalized Net Income Margin	11.66	12.05	12.3	9.03	6.45
Levered Free Cash Flow Margin	5.83	10.63	-2.25	4.55	-3.38
Unlevered Free Cash Flow Margin	6.39	10.9	-2.09	4.98	-2.97
Asset Turnover
Asset Turnover	0.7	0.75	0.69	0.7	0.56
Fixed Assets Turnover	6.01	6.08	3.84	3.57	3.01
Receivables Turnover (Average Receivables)	3.12	3.22	2.93	2.65	1.9
Inventory Turnover (Average Inventory)	4.07	3.64	3.2	2.63	1.91
Short Term Liquidity
Current Ratio	3.05	2.14	1.78	1.46	1.47
Quick Ratio	2.79	1.94	1.56	1.16	1.22
Operating Cash Flow to Current Liabilities	0.43	0.53	0.33	0.09	0.16
Days Sales Outstanding (Average Receivables)	116.94	113.3	124.57	137.86	191.99
Days Outstanding Inventory (Average Inventory)	89.63	100.33	114.09	139.13	190.87
Average Days Payable Outstanding	77	138.09	146.26	135.47	192.39
Cash Conversion Cycle (Average Days)	129.57	75.54	92.4	141.52	190.46
Long Term Solvency
Total Debt/Equity	19.38	16.61	32.47	38.05	50.15
Total Debt / Total Capital	16.23	14.24	24.51	27.56	33.4
LT Debt/Equity	-	0.01	14.88	13.14	9.9
Long-Term Debt / Total Capital	-	0.01	11.23	9.52	6.6
Total Liabilities / Total Assets	26.54	31.84	41.47	50.04	46.9
EBIT / Interest Expense	18.22	39.05	64.66	22.47	16.8
EBITDA / Interest Expense	19.55	42.09	73.49	27.59	23.49
(EBITDA - Capex) / Interest Expense	16.43	19.21	47.17	24.5	21.15
Total Debt / EBITDA	1.23	0.93	1.83	1.5	2.92
Net Debt / EBITDA	-2.71	-1.93	-0.22	0.27	1.34
Total Debt / (EBITDA - Capex)	1.46	2.04	2.85	1.69	3.24
Net Debt / (EBITDA - Capex)	-3.23	-4.22	-0.35	0.3	1.49
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	48.99	27.94	36.1	31.16	-20.59
Gross Profit, 1 Yr. Growth %	57.13	30.2	38.89	24.6	-20.64
EBITDA, 1 Yr. Growth %	44.33	35.02	37.54	32.49	-35.8
EBITA, 1 Yr. Growth %	45.12	35.58	35.34	23.32	-41.18
EBIT, 1 Yr. Growth %	44.87	34.69	30.59	22.87	-43.33
Earnings From Cont. Operations, 1 Yr. Growth %	58.17	29.16	53.63	-5.1	-82.79
Net Income, 1 Yr. Growth %	62.08	32.18	45.42	-6.38	-83.12
Normalized Net Income, 1 Yr. Growth %	58.85	32.26	38.82	-3.66	-43.25
Diluted EPS Before Extra, 1 Yr. Growth %	54.17	32.43	44.9	-5.63	-83.58
Accounts Receivable, 1 Yr. Growth %	8.32	38.37	57.77	36.5	-7.92
Inventory, 1 Yr. Growth %	86.43	10.74	79.17	82.51	-30.65
Net Property, Plant and Equip., 1 Yr. Growth %	2.3	50.34	159.1	-4.87	-6.76
Total Assets, 1 Yr. Growth %	11.61	29.3	60.76	9.3	-10.78
Tangible Book Value, 1 Yr. Growth %	4.23	-4.05	-29.85	11.19	8.2
Common Equity, 1 Yr. Growth %	5.05	20.13	18.66	3.88	-5.35
Cash From Operations, 1 Yr. Growth %	145.13	89.17	-5.65	-61.3	53.71
Capital Expenditures, 1 Yr. Growth %	-49.57	359.81	-9.32	-58.43	-42.83
Levered Free Cash Flow, 1 Yr. Growth %	-697.72	133.09	-128.81	-365.48	-158.93
Unlevered Free Cash Flow, 1 Yr. Growth %	-870.07	118.3	-126.12	-412.23	-147.4
Dividend Per Share, 1 Yr. Growth %	-	-	100	70	-82.35
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.07	38.06	31.96	33.6	2.05
Gross Profit, 2 Yr. CAGR %	6.37	43.03	34.48	31.55	-0.56
EBITDA, 2 Yr. CAGR %	1.04	39.61	36.35	35.09	-7.67
EBITA, 2 Yr. CAGR %	0.09	40.29	35.54	29.29	-14.73
EBIT, 2 Yr. CAGR %	-0.09	39.69	32.63	26.67	-16.56
Earnings From Cont. Operations, 2 Yr. CAGR %	5.67	42.93	40.87	20.75	-59.59
Net Income, 2 Yr. CAGR %	6.97	46.37	38.64	16.68	-60.25
Normalized Net Income, 2 Yr. CAGR %	6.56	44.95	35.5	15.65	-26.06
Diluted EPS Before Extra, 2 Yr. CAGR %	1.38	42.89	38.52	16.93	-60.64
Accounts Receivable, 2 Yr. CAGR %	12.24	22.43	47.75	46.75	12.12
Inventory, 2 Yr. CAGR %	28.86	43.68	40.86	80.84	12.5
Net Property, Plant and Equip., 2 Yr. CAGR %	19.19	24.02	97.37	57	-5.82
Total Assets, 2 Yr. CAGR %	38.66	20.13	44.17	32.56	-1.25
Tangible Book Value, 2 Yr. CAGR %	25.42	0	-17.96	-11.69	9.69
Common Equity, 2 Yr. CAGR %	25.86	12.33	19.39	11.03	-0.84
Cash From Operations, 2 Yr. CAGR %	15.49	115.34	33.59	-39.58	-22.88
Capital Expenditures, 2 Yr. CAGR %	80.43	52.28	104.2	-38.6	-51.25
Levered Free Cash Flow, 2 Yr. CAGR %	-8.27	273.26	-18.06	-12.55	25.05
Unlevered Free Cash Flow, 2 Yr. CAGR %	-4.08	310.01	-24.5	-9.7	21.63
Dividend Per Share, 2 Yr. CAGR %	-	-36.75	-	84.39	-45.23
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.14	10.77	37.41	31.69	12.33
Gross Profit, 3 Yr. CAGR %	11.89	13.78	41.64	31.1	11.15
EBITDA, 3 Yr. CAGR %	15.35	11.3	38.97	35.12	5.5
EBITA, 3 Yr. CAGR %	15.59	10.75	38.67	31.4	-0.48
EBIT, 3 Yr. CAGR %	15.48	10.37	36.59	29.29	-3.12
Earnings From Cont. Operations, 3 Yr. CAGR %	10.39	12.99	46.41	23.49	-36.93
Net Income, 3 Yr. CAGR %	11.29	14.79	46.05	21.63	-38.75
Normalized Net Income, 3 Yr. CAGR %	20.48	14.52	42.87	20.94	-8.78
Diluted EPS Before Extra, 3 Yr. CAGR %	7.07	10.82	43.55	21.89	-39.22
Accounts Receivable, 3 Yr. CAGR %	15.31	20.35	33.23	43.9	25.64
Inventory, 3 Yr. CAGR %	19.52	22.51	54.65	53.56	31.38
Net Property, Plant and Equip., 3 Yr. CAGR %	11.02	28.78	58.54	54.75	31.96
Total Assets, 3 Yr. CAGR %	34.56	35.46	32.38	31.46	16.17
Tangible Book Value, 3 Yr. CAGR %	25.65	14.7	-11.15	-9.21	-5.5
Common Equity, 3 Yr. CAGR %	25.81	23.92	14.41	13.98	5.27
Cash From Operations, 3 Yr. CAGR %	27.19	36.14	63.55	-11.61	-17.52
Capital Expenditures, 3 Yr. CAGR %	144.46	146.45	28.12	20.12	-40.05
Levered Free Cash Flow, 3 Yr. CAGR %	52.18	25.18	58.92	21.25	-23.34
Unlevered Free Cash Flow, 3 Yr. CAGR %	56.29	26.17	63.74	21.19	-27.17
Dividend Per Share, 3 Yr. CAGR %	-	-	-7.17	-	-15.66
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.78	13.48	17.75	19.4	21.99
Gross Profit, 5 Yr. CAGR %	14.61	15.22	20.43	20.58	22.95
EBITDA, 5 Yr. CAGR %	17.11	18.5	23.33	20.29	18.03
EBITA, 5 Yr. CAGR %	17.81	18.9	23.19	17.85	14.19
EBIT, 5 Yr. CAGR %	17.77	18.68	22.05	16.62	12.15
Earnings From Cont. Operations, 5 Yr. CAGR %	14.69	16.98	21.69	16.03	-12.51
Net Income, 5 Yr. CAGR %	15.25	18.1	21.51	15.54	-13.21
Normalized Net Income, 5 Yr. CAGR %	14.74	21.38	26.27	14.97	9.78
Diluted EPS Before Extra, 5 Yr. CAGR %	10.59	15.44	18.69	13.23	-14.45
Accounts Receivable, 5 Yr. CAGR %	17.5	17.43	27.33	30.29	24.34
Inventory, 5 Yr. CAGR %	8.62	17.32	27.64	43.16	36.17
Net Property, Plant and Equip., 5 Yr. CAGR %	5.17	14.23	39.75	39.4	28.73
Total Assets, 5 Yr. CAGR %	22.09	26.29	38.32	34.29	17.74
Tangible Book Value, 5 Yr. CAGR %	19.11	15.85	5.95	3.31	-3.34
Common Equity, 5 Yr. CAGR %	19.09	21.22	23.2	18.59	8.04
Cash From Operations, 5 Yr. CAGR %	34.59	38.54	29.71	-1.63	21.08
Capital Expenditures, 5 Yr. CAGR %	16.1	75.64	127.48	41.35	-12.96
Levered Free Cash Flow, 5 Yr. CAGR %	30.31	50.74	18.8	8.45	44.39
Unlevered Free Cash Flow, 5 Yr. CAGR %	32.7	51.51	16.83	10.37	45.38
Dividend Per Share, 5 Yr. CAGR %	-	-12.23	-	-	-24.83